Olga Selioutski, Katherine Grzesik, Olga N

Slides:



Advertisements
Similar presentations
Peter L. Fisher, Adam J. Noble  Seizure - European Journal of Epilepsy 
Advertisements

Monte Carlo modeling of the Siemens Optifocus multileaf collimator
Gamma knife radiosurgery for the treatment of recurrent seizures after incomplete anterior temporal lobectomy  Der-Jen Yen, Wen-Yuh Chung, Yang-Hsin Shih,
Seizure - European Journal of Epilepsy
Temporal-spatial characteristics of phase-amplitude coupling in electrocorticogram for human temporal lobe epilepsy  Ruihua Zhang, Ye Ren, Chunyan Liu,
Ian Morrison, Saif S.M. Razvi  Seizure - European Journal of Epilepsy 
Measurement of levetiracetam drug levels to assist with seizure control and monitoring of drug interactions with other anti-epileptic medications (AEMs) 
Ca analysis: An Excel based program for the analysis of intracellular calcium transients including multiple, simultaneous regression analysis  David J.
Tong Chen, Liang Guo  Seizure - European Journal of Epilepsy 
Long-term follow-up of cortical hyperexcitability in Japanese Unverricht–Lundborg disease  Katsuya Kobayashi, Takefumi Hitomi, Riki Matsumoto, Takayuki.
Attitudes of employees of service and trading companies towards people with epilepsy and their professional activity in Poland  Talarska Dorota, Monika.
Antiepileptic drug therapy the story so far
Brain stimulation as a neuromodulatory epilepsy therapy
Has disability discrimination legislation changed the legal framework for epilepsy in the United Kingdom?  Philip Lee  Seizure - European Journal of Epilepsy 
Comparing paediatric intravenous phenytoin doses using physiologically based pharmacokinetic (PBPK) modelling software  Hannah Batchelor, Richard Appleton,
Patients with epilepsy are at an increased risk of subsequent stroke: A population-based cohort study  Chen-Shu Chang, Chun-Hui Liao, Che-Chen Lin, Hsien-Yuan.
Mesial temporal lobe epilepsy associated with KCNT1 mutation
Central apnea at complex partial seizure onset
Retention, dosing, tolerability and patient reported seizure outcome of Zonisamide as only add-on treatment under real-life conditions in adult patients.
Daniel Weber, David McCarthy, Jay Pathmanathan 
Leo L. K. Chen, Zulfi Haneef, Andrew Dorsch, Inna Keselman, John M
Presentation of adult mitochondrial epilepsy
Coral M. Stredny, Nicholas S. Abend, Tobias Loddenkemper 
Anshuman Sengupta, Ali Mahmoud, Shwe Z. Tun, Peter Goulding 
S. Kılınç, C. Campbell  Seizure - European Journal of Epilepsy 
Color density spectral array of bilateral bispectral index system: Electroencephalographic correlate in comatose patients with nonconvulsive status epilepticus 
Pegah Afra, Christopher C. Jouny, Gregory K. Bergey 
Etiologic features of newly diagnosed epilepsy: Hospital-based study of 892 consecutive patients in West China  Yang Si, Ling Liu, Jia Hu, Jie Mu, Jia-jia.
Mutation in the mitochondrial tRNAIle gene causes progressive myoclonus epilepsy  Gábor Zsurka, Felicitas Becker, Markus Heinen, Hans-Jürgen Gdynia, Holger.
Smoking reduces serum levels of lamotrigine
Identifying seizure onset zone from electrocorticographic recordings: A machine learning approach based on phase locking value  Bahareh Elahian, Mohammed.
The experience of adjusting to a diagnosis of non-epileptic attack disorder (NEAD) and the subsequent process of psychological therapy  Caroline Wyatt,
TLR4, ATF-3 and IL8 inflammation mediator expression correlates with seizure frequency in human epileptic brain tissue  Katharina Pernhorst, Stefan Herms,
Simple autonomic seizures and ictal enuresis
Growth and endocrine function in children with Dravet syndrome
Seizure freedom with VNS monotherapy: A case report
Depression and anxiety in childhood epilepsy: A review
What patients say about living with psychogenic nonepileptic seizures: A systematic synthesis of qualitative studies  Gregg H. Rawlings, Markus Reuber 
W. Owen Pickrell, Arron S. Lacey, Rhys H. Thomas, Ronan A
Vaishnav Krishnan, Erick Tarula, Matthew P. Anderson, Khalid A
Fluctuating and constant valproate administration gives equivalent seizure control in rats with genetic and acquired epilepsy  S. Dedeurwaerdere, L. van.
The anti-ictogenic effects of levetiracetam are mirrored by interictal spiking and high- frequency oscillation changes in a model of temporal lobe epilepsy 
Epileptic spasms: Evidence for oral corticosteroids and implications for low and middle income countries  Sharika V. Raga, Jo M. Wilmshurst  Seizure -
Internet-based knowledge management database for children and adults with epilepsy: A possible model project for evidence-based medicine in the future 
X. Tong, N. Ratnaraj, P.N. Patsalos 
Ali A. Asadi-Pooya, Mehrdad Emami, Alireza Nikseresht 
Peter L. Fisher, Adam J. Noble  Seizure - European Journal of Epilepsy 
Computational models of epilepsy
Sudden death in epilepsy: Insights from the last 25 years
Milen Pavlović, Nebojša Jović, Tatjana Pekmezović 
Cortical stimulation parameters for functional mapping
Recording temporal lobe epileptic activity with MEG in a light-weight magnetic shield  Evelien Carrette, Marc Op de Beeck, Mathieu Bourguignon, Paul Boon,
Pharmacokinetic parameter sets of alfentanil revisited: optimal parameters for use in target controlled infusion and anaesthesia display systems  N Sigmond,
Self reported adverse effects of mono and polytherapy for epilepsy
How important is the seizure onset zone for seizure dynamics?
Antiepileptic drug use in Austrian nursing home residents
Comparing paediatric intravenous phenytoin doses using physiologically based pharmacokinetic (PBPK) modelling software  Hannah Batchelor, Richard Appleton,
Zhang Lin, Qi Si, Zou Xiaoyi  Seizure - European Journal of Epilepsy 
Lindsey Hunter, Peter Sidebotham, Richard Appleton, Colin Dunkley 
Long-term results with vagus nerve stimulation in children with pharmacoresistant epilepsy  Andreas V. Alexopoulos, Prakash Kotagal, Tobias Loddenkemper,
Examining a community model of epilepsy care for people with learning disabilities  M. Reuber, J. Gore, J. Wolstenhome, P. Jonas, C. Frankson, C. Murray,
Elevated serum S-100B levels in children with temporal lobe epilepsy
Johan Zelano, Eva Kumlien  Seizure - European Journal of Epilepsy 
S. Ginart, M. Caputo, D. Corach, A. Sala 
Katherine T. Hamilton, Christopher T
Unusual ipsilateral hyperkinetic automatisms in SMA seizures
Sequencing of the highly polymorphic STR locus SE33
Feasibility of stereotactic body radiotherapy for locally-advanced non-small cell lung cancer  Katrina Woodford, Vanessa Panettieri, Trieumy Tran Le,
Economic Burden of Epilepsy in Rural Ituri, Democratic Republic of Congo  Joseph Nelson Siewe Fodjo, Michel Mandro, Deogratias Wonya'rossi, Yasemine Inaç,
Clinical and Translational Radiation Oncology
Presentation transcript:

Evaluation of phenytoin serum levels following a loading dose in the acute hospital setting  Olga Selioutski, Katherine Grzesik, Olga N. Vasilyeva, Ágúst Hilmarsson, A. James Fessler, Lynn Liu, Robert A. Gross  Seizure - European Journal of Epilepsy  Volume 52, Pages 199-204 (November 2017) DOI: 10.1016/j.seizure.2017.10.006 Copyright © 2017 British Epilepsy Association Terms and Conditions

Fig. 1 Cumulative weight adjusted Phenytoin (PHT)/Fosphenytoin (FOS) dose vs. Total PHT (tPHT) serum level obtained between 2 and 24hours post initial loading dose. Please use color in publication. Boxplots demonstrate the relationship between cumulative weight-based PHT/FOS dose and tPHT serum for each of the 3 medication regimen groups. X axis: weight-based ranges of cumulative dose of PHT/FOS in mg/kg ([3-15), [15-20), or [20-55)) prior to level drawn. Y axis: total PHT serum level in μg/mL. Red boxes: group receiving a single loading dose (LD Only). Green boxes: group receiving a single loading dose followed by at least one maintenance dose (LD+MD(s)). Blue boxes: group receiving multiple loading doses (Multiple LDs). The red diamond is the mean and black bar is the median tPHT serum level for each subgroup. Below each boxplot is the total number of serum tPHT levels (N) for each subgroup, the percent of levels≥20μg/mL (%) and the last hour post the loading dose administration when tPHT level ≥20μg/mL was present. Asterisks (*) indicate p<0.05 for Tukey’s test of differences. Seizure - European Journal of Epilepsy 2017 52, 199-204DOI: (10.1016/j.seizure.2017.10.006) Copyright © 2017 British Epilepsy Association Terms and Conditions

Fig. 2 Total PHT (tPHT) serum levels obtained two to 24hours in a group receiving a single Phenytoin (PHT)/Fosphenytoin (FOS) loading dose. The weight-based loading dose is divided into [3-15), [15-20), or [20-51) mg/kg subgroups. X axis: hours since loading dose. Y axis: total PHT serum level (μg/ml). Blue lines represent linear model fit. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.) Seizure - European Journal of Epilepsy 2017 52, 199-204DOI: (10.1016/j.seizure.2017.10.006) Copyright © 2017 British Epilepsy Association Terms and Conditions

Fig. 3 Preset loading dose of 500, 1000 or 1500mg/PE converted to weight-based value and correlated with subsequent total phenytoin serum levels obtained between 2 and 24hours post infusion. The clear boxplots represent Phenytoin weight-based loading doses (mg/kg for each of the present loading dose value). The white boxplots represent the corresponding serum tPHT levels (μg/mL) obtained between 2 and 24h post infusion. Below each boxplot is the total number of values in each subgroup (N), the percent of tPHT serum levels≥20μg/mL (%) and the last hour when tPHT level of≥20μg/mL was recorded. Seizure - European Journal of Epilepsy 2017 52, 199-204DOI: (10.1016/j.seizure.2017.10.006) Copyright © 2017 British Epilepsy Association Terms and Conditions

Fig. 4 Correlation between free and total concomitant Phenytoin (PHT) serum levels. Color should be used in print. X axis: total PHT serum level (μg/mL). Y axis: free PHT serum level (μg/mL). The thin black lines border free to total PHT serum level ratios of 10% and 12%. The thick black line is the linear model fit to the data. The data points colored blue if the ratio of free to total PHT level is within 10–12%; red with frPHT level >2μg/mL and tPHT level <20μg/mL; black if frPHT <2μg/mL and tPHT level ≥ 20μg/mL Seizure - European Journal of Epilepsy 2017 52, 199-204DOI: (10.1016/j.seizure.2017.10.006) Copyright © 2017 British Epilepsy Association Terms and Conditions